Vitamin E-bisphosphonate conjugates: A new therapeutic approach targeting pathological bone loss associated with osteoporosis

维生素 E-二磷酸盐结合物：一种针对与骨质疏松症相关的病理性骨丢失的新治疗方法

• 批准号: nhmrc : 1050694
• 负责人: Prof Andreas Evdokiou
• 金额: $ 31.47万
• 依托单位: The University of Adelaide
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2013
• 资助国家: 澳大利亚
• 起止时间: 2013-01-01 至 2015-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/vitamin-e-bisphosphonate-associated-osteoporosis/112173
• 关键词: Vitamin; bisphosphonate; conjugates; new; therapeutic

Approximately 2 million Australians have osteoporosis, a disease which increases the risk of fracture and whose monetary and social costs are large and growing. The objective of this proposal is to exploit the osteotropic properties of novel compounds of

大约有200万澳大利亚人患有骨质疏松症，这种疾病增加了骨折的风险，其货币和社会成本很大，而且还在增加。该提议的目的是开发式I的新化合物的骨诱导性质，